MND Australia has just updated the Riluzole fact sheet to address new research that has been recently released about the medication. The main updates are to the sections describing the evidence about Riluzole, including the new study, and the advice on survival.

New evidence suggests the medication probably prolongs average survival by 6 to 19 months.

Please see the MND Australia Update Fact Sheet - Riluzole for further information.